| Financial Year |
March 31 2023 |
| Monetary Funds |
2,213,029,291.00 |
| Held-for-trading Financial Assets |
80,520,667.00 |
| Notes Receivable |
347,705.00 |
| Accounts Receivable |
1,832,790,418.00 |
| Advances to Suppliers |
18,447,670.00 |
| Other Receivables |
121,695,223.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
777.00 |
| Dividend Receivable |
-- |
| Inventories |
1,601,841,674.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,356,495,333.00 |
| Other Current Assets |
36,260,571.00 |
| Total Current Assets |
7,293,023,519.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
28,637,015.00 |
| Investment Properties |
23,968,423.00 |
| Fixed Assetes |
2,780,336,580.00 |
| Under-construction Projects |
645,212,148.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
102,775,916.00 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,162,837.00 |
| Deferred Income Tax Assets |
106,379,827.00 |
| Other Non-Current Assets |
2,211,721,664.00 |
| Sub-Total of Non-Current Assets |
6,127,439,667.00 |
| Total Assets |
13,420,463,186.00 |
| Short-Term Loans |
2,020,892,571.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
219,808,850.00 |
| Accounts Payable |
1,446,027,613.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
166,835,977.00 |
| Taxes Payable |
55,899,015.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
158,805,404.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,916,401.00 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
4,100,787,202.00 |
| Long-term Loans |
375,366,362.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
12,331,696.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
709,225,265.00 |
| Total Liabilities |
4,810,012,467.00 |
| Paid-In Capital(Or Share Stock) |
1,904,281,825.00 |
| Capital Surplus |
472,657,241.00 |
| Surplus Reserve |
788,053,987.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,400,982,764.00 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,610,450,719.00 |
| Owner's Equity（Stockholder's Equity） |
8,610,450,719.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,420,463,186.00 |
